Get Healthy!

Results for search "Weight Loss".

Health News Results - 193

Can't Exercise Every Day? Weight Loss Is Still Possible

Folks can lose weight even if they pack all their weekly exercise into one or two days, a new study finds.

Guidelines recommend that people get at least 150 minutes a week of moderate physical activity or 75 minutes a week of vigorous exercise.

“Weekend warriors” who condense all that exercise into one or two days each week can lose about the same amount of weight as people who ...

Novo Nordisk Settles Lawsuits Over Copycat Versions of Ozempic, Wegovy

Novo Nordisk has settled lawsuits against two Florida businesses that claimed to sell copycat versions of its popular weight-loss drugs Ozempic and Wegovy.

The Danish drugmaker announced the settlements Friday, according to NBC News

The move capped a legal battle that began in late November when the company filed 12 lawsuits against clinics, medical spas and compound...

You Probably Can't 'Exercise Away' the Calories in Sodas: Study

Don't expect to sweat away the heart risks posed by sugary sodas and drinks, a new study warns.

Canadian researchers found that even if the recommended 150 minutes of weekly physical activity protects against cardiovascular disease, it's not enough to counter the adverse effects of sugar-sweetened beverages.

“Physical activity reduces the risk of cardiovascular disease associated ...

A Cardiologist Answers Your Questions on New Weight-Loss Meds

Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says.

However, these medications help the heart best when combined with lifestyle changes like more exercise and a healthy diet, according to

Weight-Loss Med Zepbound Lowers High Blood Pressure in Obese People

The weight-loss drug Zepbound provides more health benefits than dropping pounds and controlling diabetes, a new study shows.

It also appears to help people with obesity manage their high blood pressure, results show.

Patients taking Zepbound (tirzepatide) experienced a significant reduction in their systolic blood pressure, the top number in a blood pressure reading, according to a...

Could Eating Kimchi Each Day Help Folks Stay Slim?

It's been a staple at Korean dinner tables for centuries, and the fermented veggie concoction known as kimchi is increasingly familiar to Americans.

Now, Korean researchers say a few servings of the spicy food each day might help stave off weight gain.

"Consumption of 1–3 servings/day of total kimchi was associated with a lower risk of obesity in men," and smaller amounts were l...

Practice 'Self-Compassion' to Help Reach Your Weight Loss Goals

It's not easy to lose weight, especially when facing a world filled with the temptation of tasty treats and rich, delicious meals.

But being kind to yourself can make the difference when it comes to sticking to a diet, a new study reports.

Dieters who practice self-compassion -- showing themselves the same care and kindness they'd show loved ones -- are better able to get past an ov...

Losing Weight for No Reason? See Your Doctor

If you ever find yourself losing weight, even though you're not dieting or upping your exercise, go see a doctor. It can be a sign of cancer, researchers report.

“Unexpected weight loss can come from cancer or many other conditions,” said study senior author Dr. Brian Wolpin. He directs the Gastrointestinal Cancer ...

When Weight Loss Cures Diabetes, Risks for Heart Disease Tumble, Too

Folks who drop pounds to help control their diabetes receive other substantial heath benefits for all their efforts, a new study says.

Substantial weight loss that led to even a short-lived remission in type 2 diabetes also prompted a 40% lower rate in heart disease and a 33% lower rate of kidney disease, researchers report in the Jan. 18 issue of the journal

  • Dennis Thompson HealthDay Reporter
  • |
  • January 19, 2024
  • |
  • Full Page
  • FDA Finds No Link to Suicide With Drugs Like Wegovy, Ozempic

    Drugs like Wegovy and Ozempic, which have become a wildly popular way to lose weight or battle diabetes, show no link to suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday.

    “Our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions,” an FDA

  • Robin Foster HealthDay Reporter
  • |
  • January 12, 2024
  • |
  • Full Page
  • Reddit Posts Show Ozempic, Wegovy Cutting Users' Alcohol Use

    Social media is abuzz with the possibility that newfangled weight loss drugs can also reduce cravings for alcohol, a new study says.

    Across a number of Reddit threads, users of weight-loss drugs like Ozempic reported that they felt less need to drink beer, wine and liquor.

    Threads bearing titles like “Did scientists accidentally invent an anti-addiction drug?” and “I don't kno...

    BMI or Body Fat Percentage: Measure Both to Gauge Health

    So, the new year has begun and everyone is trying to losing weight, but what is the best way to determine how many pounds you need to shed -- BMI or body fat?

    “Both body fat percentage and BMI are important to monitor. They give you a good starting point, but you don't want to use BMI alone to make a health diagnosis or define body fat,” said

  • Robin Foster HealthDay Reporter
  • |
  • January 6, 2024
  • |
  • Full Page
  • Study Shows No Sign Ozempic, Wegovy Raise Odds for Suicidal Thoughts

    Folks who take Ozempic or Wegovy for diabetes and weight loss need not worry about a higher risk of suicidal thoughts or feelings while on the medications, a new, large review finds.

    In the study, which was funded by the U.S. National Institutes of Health, researchers turned to a database of more than 100 million patient records to measure the risks of suicidal ideation among people using...

    FDA Looking Into New Risks With Popular Weight-Loss Drugs

    The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.

    In a quarterly report...

    Going Low-Carb? Avoid Meat to Keep the Weight Off Long-Term

    New research offers yet more evidence that veggies, whole grains and low-fat dairy products are good for you in the long run.

    "Our study goes beyond the simple question of, 'To carb or not to carb?'" said lead study author Binkai Liu, a research assistant in the nutrition department at Harvard T.H. Chan School of Public Healt...

    FDA Warns of Counterfeit Ozempic

    The U.S. Food and Drug Administration has uncovered counterfeit Ozempic shots in the legitimate U.S. drug supply chain, and is warning patients to be on their guard.

    The FDA said Thursday that it has seized thousands of counterfeit dos...

    Gradual Weight Loss Using Meds Helps Folks With Arthritis Live Longer

    Using a weight-loss medication to help you shed pounds gradually appears to help extend life for people with arthritis of the hips or knees, a new study finds.

    However, folks with arthritis who dropped pounds very quickly showed no benefit in terms of survival, and even a slight uptick in their risk for heart disease, a team of American and Chinese researchers found.

    The study's tak...

    Oprah Winfrey Says She Uses Weight-Loss Medication

    Media mogul Oprah Winfrey confirmed Wednesday that she has used a weight-loss medication to help her shed pounds and get healthy.

    Winfrey has added the drug to a regimen that includes regular exercise and other lifestyle tweaks, People magazine reported.

    Weight fluctuations "occupied five decades of space in m...

    Most Older Americans Think Medicare Should Cover Weight-Loss Meds: Poll

    An overwhelming majority of older Americans think health insurers and Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy or Zepbound, a new survey has found.

    More than four out of five older adults (83%) think insurance companies should pay for drugs that help obese people manage their weight, according to poll re...

    No Sign that Ozempic, Wegovy Pose Threat to the Fetus: Study

    The diabetes and weight-loss drug Ozempic does not appear to harm a developing fetus when taken by pregnant women, a new study reports.

    Researchers found no elevated risk of birth defects among newborns of women who took medications to control their type 2 diabetes, compared with those who took insulin.

    During the decade-long study, researchers saw an increase in people trying to co...

    Pounds Return Once Zepbound Users Quit the Weight-Loss Drug: Study

    Folks who take the blockbuster weight-loss med tirzepatide (Zepbound) may regain much of the weight they lost soon after discontinuing it, new research shows.

    A trial funded by Eli Lilly, the injected drug's maker, found that “in patients with obesity or overweight, withdrawing tirzepatide led to substantial regain of weight."

    On the other hand, continuing on with tirzepatide kep...

    New Weight-Loss Drug Zepbound Is Now Available, Company Says

    The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday.

    "Today opens another chapter for adults living with obesity who have been looking for a new treatment option like Zepbound," Rhonda Pacheco, group vice president of Lilly Diabetes and Obesity, U.S., said in a company

  • Robin Foster HealthDay Reporter
  • |
  • December 6, 2023
  • |
  • Full Page
  • Mounjaro Beats Ozempic for Weight Loss in Early Trial

    WEDNESDAY, Nov. 29, 2023 (Healthday News) -- The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.

    Both Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic the effects of the gut hormone GLP-1, which triggers insulin production, helps control appetite and slows the movement of food through th...

    Experimental Weight-Loss Drug Slashed Fat in Livers of Obese People

    Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.

    A wider study, published in June, found that retatrutide helped obese people lose about a quarter of their sta...

    Wegovy Cuts Heart Risks by 20% in Large Trial

    MONDAY, Nov. 13, 2023 (Healthday News) -- In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.

    The results from this large, international study had been eagerly awaited by scientists and doctors alike. Why? It is the first ...

    FDA Investigating Hospitalizations Linked to Counterfeit Ozempic

    The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides.

    At least one of these reports includes mention of a counterfeit version of the Novo Nordisk medication Ozempic, CBS News reported.

    Ozempic and Wegovy, another semaglutide med...

    Doctors: Want Patients to Lose Weight? Stay Upbeat

    When doctors advise patients to lose weight, an optimistic approach is more likely to get results.

    Researchers found that patients were more likely to participate in the recommended program and shed pounds if doctors presented obesity treatments as an “opportunity.” They compared that upbeat approach to emphasizing the negative consequences of obesity or using neutral language.

    In Study, Diabetes Drug Mounjaro Helped Dieters Shed an Average of 60 Pounds

    A new trial demonstrates the power of the diabetes drug Mounjaro in fighting obesity, helping folks who used the medication lose about 60 pounds.

    "In this study, people who added tirzepatide [Mounjaro] to diet and exercise saw greater, longer-lasting weight reduction than those taking placebo," Dr. Jeff Emmick<...

    Wegovy, Ozempic Help Folks Lose Weight, But How?

    As many doctors and patients hail the advent of weight-loss drugs like Ozempic and Wegovy as the perfect fix for obesity, some experts are urging caution.

    The drugs are not well-tolerated by everyone struggling with obesity. For some folks, the weight piles back on as soon as the medication stops. There are also financial and ethical considerations, according to a commentary published onl...

    Study Confirms Risk of Gastro Issues for People Taking Wegovy, Ozempic

    While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects.

    Known as GLP-1 agonists, they may increase the risk of stomach paralysis, pancreatitis and bowel obstruction, scientists found.

    "Although the incidence of these adverse events are relatively rare, af...

    FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines

    Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.

    The U.S. Food and Drug Administration recently made the label update for the drug made by ...

    Early Morning Exercise May Be Best for Weight Control

    When it comes to staying trim, timing may be everything.

    That's according to new research that found adults who routinely engaged in moderate-to-vigorous exercise early in the morning were less likely to be overweight or obese than those who worked out later in the day.

    “For individuals who exercise regularly, their body mass index [BMI] is 2 units lower and waist circumference is...

    Pediatricians' Group Warns Against Keto Diet for Kids With Diabetes

    Low-carb diets may be all the rage, but they're not for kids with diabetes, according to the American Academy of Pediatrics (AAP).

    In a new report, the AAP says that low-carbohydrate diets cannot be recommended for children or teenagers with either type 1 or type 2 diabetes. That's because there's little evidence they're helpful, but there are concerns about restricting kids' diets to tha...

    In Small Study, Ozempic Helped People With Type 1 Diabetes Quit Insulin Treatments

    The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots.

    Experts emphasized that the findings

    Should Kids Take Ozempic, Wegovy? The Idea Has Some Experts Worried

    Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn't mean they're good for everyone.

    Glucagon-like peptide-1 receptor agonists (GLP-1RA) may be dangerous for children, warned researchers at University of California, Irvine.

    Treating childhood obesity and type 2 diabetes with these injected medications may have unintended and adverse consequences in p...

    Keeping Weight Stable Key to Reaching 90, 100 for Women

    For women, keeping a stable weight after the age of 60 may boost their odds of reaching the advanced ages of 90, 95 or even 100.

    Older women with a more stable weight were 1.2 to 2 times more likely to live that long than those who lost 5% or more of their weight, the study showed.

    Women who unintentionally lost weight were 51% less likely to survive to the age of 90. Gaining ...

    Wegovy May Be Valuable New Option for Heart Failure Patients

    Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

    Now, injected Wegovy could prove a boon for many patients battling heart failure, a new study suggests. The trial results were presented Friday in Amsterdam at the annual meeting of the European Society of C...

    What's Your Exercise 'Fat-Burning Zone'?

    A more personalized approach to exercise may be necessary, claims a new study that found fat burning varied widely between individuals.

    Even worse, this rate often does not align with the “fat-burning zone” on commercial exercise machines, the researchers added.

    Clinical exercise testing, a diagnostic procedure to measure a person's physiological response to exercise, may be a ...

    Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024

    As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.

    The new plan extends by months existing restrictions and means patients who are not already taking the medication will have to wait to start.

    “We are going to continue to supply the marke...

    Wegovy Lowered Users' Heart Risks in New Trial

    A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect.

    Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday.

    “People living with obesity have an increased risk of cardiovascular disease but, to date, there are no approved weight-management medications ...

    Lawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused 'Stomach Paralysis'

    A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.

    The lawsuit seeks “very significa...

    Water Fasting: Is It Safe? Is It for You?

    Water fasting has become one of the trendiest new weight-loss sensations, touted by former athletes and wellness gurus.

    But whatever weight is lost during a water fast can come back quickly, while other health benefits fade fast, according to a

  • Dennis Thompson HealthDay Reporter
  • |
  • July 12, 2023
  • |
  • Full Page
  • Risk of Suicidal Thoughts With Popular Weight-Loss Drugs Being Investigated by European Regulators

    The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm.

    Three case reports from Iceland spurred the agency's safety committee to conduct a medication review, CNN reported Monday. The EMA is Europe's equivalent of the U.S. Food and Drug Administration.

    The...

    In Study, Almost Half of Obese Teens Were No Longer So After Taking Wegovy/Ozempic

    The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too.

    This trial, funded by drug maker Novo Nordisk, found that nearly half of all adolescents on semaglutide (Wegovy/Ozempic) were able to achieve a healthy weight in about 17 months.

    Semaglutide is a GLP-1 receptor...

    Taking Ozempic, Wegovy? Stop Before Surgery, Anesthesiologists Say

    The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.

    Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor agonists cause digestion to slow down, which decreases hunger and reduces how much people eat.

    That food left in the...

    Exercise + Weight Loss Perfect Combo to Fight Diabetes

    Pairing exercise with a 10% weight loss can make a major health improvement in people living with obesity and prediabetes, a new study says.

    Building in regular exercise more than doubled sensitivity to insulin compared to just weight loss alone. This has the potential to prevent or delay prediabetes from progressing into type 2 diabetes while also decreasing the risk of heart diseas...

    New Competitor to Wegovy Shows Promise in Clinical Trials

    An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.

    Retatrutide helped people with obesity drop about one-quarter of their starting weight, on average, during 48 weeks taking the drug, according to phase 2 trial results published online June 26 in the

  • Dennis Thompson HealthDay Reporter
  • |
  • June 27, 2023
  • |
  • Full Page
  • Weight-Loss Surgery Can Keep Diabetes at Bay for Years: Study

    Gastric bypass surgery is a potential long-term cure for type 2 diabetes, especially if the procedure is performed before the disease progresses, a new study argues.

    Among a large group of obese people with type 2 diabetes, about half achieved remission for an average seven years after undergoing gastric bypass surgery -- the longest follow-up ever for such a group, researchers said.

    <...

    New Drugs Line Up to Challenge Ozempic, Wegovy for Weight Loss

    After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed.

    Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinical trials from would-be competitors were unveiled at this year's annual meeting of the American Diabetes Association (A...

    Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic

    The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration.

    In a sta...

    Show All Health News Results